<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">25081498</PMID><DateCompleted><Year>2015</Year><Month>11</Month><Day>27</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1573-2576</ISSN><JournalIssue CitedMedium="Internet"><Volume>38</Volume><Issue>2</Issue><PubDate><Year>2015</Year><Month>Apr</Month></PubDate></JournalIssue><Title>Inflammation</Title><ISOAbbreviation>Inflammation</ISOAbbreviation></Journal><ArticleTitle>Association of interleukin-6-572C/G gene polymorphism and serum or cerebrospinal fluid interleukin-6 level with enterovirus 71 encephalitis in Chinese Han patients with hand, foot, and mouth disease.</ArticleTitle><Pagination><StartPage>728</StartPage><EndPage>735</EndPage><MedlinePgn>728-35</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10753-014-9983-1</ELocationID><Abstract><AbstractText>Interleukin-6 (IL-6), as one of pro-inflammatory cytokines, plays a key role in Enterovirus 71 (EV71) encephalitis. We investigated the association of IL-6-572C/G polymorphism and serum or cerebrospinal fluid (CSF) IL-6 level with EV71 encephalitis in patients with hand, foot, and mouth disease (HFMD). This study was carried out in 59 Chinese Han patients with EV71 encephalitis, 128 EV71-related HFMD without complications, and 232 controls. The IL-6-572C/G polymorphism was detected by polymerase chain reaction-restricted fragment length polymorphism gene analysis. Serum or CSF IL-6 levels were determined using a commercial enzyme-linked immunosorbent assay. The patients with EV71 encephalitis had a higher frequency of IL-6-572GG/GC genotype compared to the patients with EV71-related HFMD without encephalitis complications (40.7 vs. 15.6 %, odds ratio (OR)=3.70, 95 % confidence interval (CI)=1.83-7.50, p=0.001). Similarly, the frequency of IL-6-572 G allele among the patients with EV71 encephalitis was also higher than that of patients with EV71-related HFMD without encephalitis complications (23.7 vs. 8.6 %, OR=3.31, 95 % CI=1.80-6.08, p&lt;0.001). Serum IL-6 levels in G carries (CG + GG) (195.1 &#xb1; 11.8 pg/ml) elevated significantly compared to CC homozygotes (167.7 &#xb1; 6.7 pg/ml) in EV71-infected patients (p&lt;0.001), but no significant differences were observed in CSF IL-6 levels among different genotypes in patients with EV71 encephalitis. Furthermore, G carriers (GG + GC) (10.6 &#xb1;.29 mg/l) had significantly higher blood CRP levels compared to CC homozygotes (9.31 &#xb1; 1.93 mg/l) in patients with EV71 encephalitis (p=0.005). These findings suggested that IL-6-572 G allele was significantly associated with the susceptibility to EV71 encephalitis in Chinese Han patients, and IL-6-572 G allele might elevate the risk to EV71 encephalitis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Aiyun</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Neurology &amp; Rehabilitation, The Affiliated Women &amp; Children Hospital of Qingdao University Medical School, 6 Tongfu Road, Qingdao, 266034 , Shandong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Jian</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Peipei</ForeName><Initials>P</Initials></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Zongbo</ForeName><Initials>Z</Initials></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Mei</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Jinju</ForeName><Initials>J</Initials></Author><Author ValidYN="Y"><LastName>Han</LastName><ForeName>Zhenliang</ForeName><Initials>Z</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Inflammation</MedlineTA><NlmUniqueID>7600105</NlmUniqueID><ISSNLinking>0360-3997</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D044466" MajorTopicYN="N">Asian People</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018792" MajorTopicYN="N">Encephalitis, Viral</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056726" MajorTopicYN="N">Genetic Association Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000134" MajorTopicYN="N">cerebrospinal fluid</QualifierName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011110" MajorTopicYN="N">Polymorphism, Genetic</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2014</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2014</Year><Month>8</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2015</Year><Month>12</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">25081498</ArticleId><ArticleId IdType="doi">10.1007/s10753-014-9983-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ann Acad Med Singap. 2003 May;32(3):381-7</Citation><ArticleIdList><ArticleId IdType="pubmed">12854382</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013;8(2):e57591</Citation><ArticleIdList><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Biochem J. 1990 Feb 1;265(3):621-36</Citation><ArticleIdList><ArticleId IdType="pubmed">1689567</ArticleId></ArticleIdList></Reference><Reference><Citation>Hum Immunol. 2007 Sep;68(9):756-60</Citation><ArticleIdList><ArticleId IdType="pubmed">17869650</ArticleId></ArticleIdList></Reference><Reference><Citation>Adv Clin Chem. 2009;48:111-36</Citation><ArticleIdList><ArticleId IdType="pubmed">19803417</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol Sin. 2011 Aug;26(4):221-8</Citation><ArticleIdList><ArticleId IdType="pubmed">21847753</ArticleId></ArticleIdList></Reference><Reference><Citation>PLoS One. 2013 Jun 28;8(6):e67430</Citation><ArticleIdList><ArticleId IdType="pubmed">23840697</ArticleId></ArticleIdList></Reference><Reference><Citation>Rheumatology (Oxford). 2001 Jun;40(6):656-61</Citation><ArticleIdList><ArticleId IdType="pubmed">11426023</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Infect Dis. 2009 Jan;15(1):79-82</Citation><ArticleIdList><ArticleId IdType="pubmed">19116058</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Neurol. 2010 Nov;9(11):1097-105</Citation><ArticleIdList><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2009 Jul;47(7):2351-2</Citation><ArticleIdList><ArticleId IdType="pubmed">19439545</ArticleId></ArticleIdList></Reference><Reference><Citation>J Am Geriatr Soc. 2005 Sep;53(9):1552-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16137286</ArticleId></ArticleIdList></Reference><Reference><Citation>Acta Paediatr. 2002;91(6):632-5</Citation><ArticleIdList><ArticleId IdType="pubmed">12162592</ArticleId></ArticleIdList></Reference><Reference><Citation>FEMS Microbiol Rev. 2002 Mar;26(1):91-107</Citation><ArticleIdList><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Mol Sci. 2012 Oct 22;13(10):13667-79</Citation><ArticleIdList><ArticleId IdType="pubmed">23202972</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Invest. 1998 Oct 1;102(7):1369-76</Citation><ArticleIdList><ArticleId IdType="pubmed">9769329</ArticleId></ArticleIdList></Reference><Reference><Citation>Pediatr Res. 2006 Oct;60(4):466-71</Citation><ArticleIdList><ArticleId IdType="pubmed">16940249</ArticleId></ArticleIdList></Reference><Reference><Citation>Microbes Infect. 2010 Jul;12(7):505-10</Citation><ArticleIdList><ArticleId IdType="pubmed">20348010</ArticleId></ArticleIdList></Reference><Reference><Citation>Chin Med J (Engl). 2012 Apr;125(7):1261-5</Citation><ArticleIdList><ArticleId IdType="pubmed">22613598</ArticleId></ArticleIdList></Reference><Reference><Citation>Mol Vis. 2011;17:2552-63</Citation><ArticleIdList><ArticleId IdType="pubmed">22025890</ArticleId></ArticleIdList></Reference><Reference><Citation>J Rheumatol. 2006 Apr;33(4):703-8</Citation><ArticleIdList><ArticleId IdType="pubmed">16583473</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interferon Cytokine Res. 2010 Dec;30(12):917-21</Citation><ArticleIdList><ArticleId IdType="pubmed">20973681</ArticleId></ArticleIdList></Reference><Reference><Citation>Pharmacogenetics. 2001 Nov;11(8):699-701</Citation><ArticleIdList><ArticleId IdType="pubmed">11692078</ArticleId></ArticleIdList></Reference><Reference><Citation>J Clin Microbiol. 2005 Aug;43(8):3835-9</Citation><ArticleIdList><ArticleId IdType="pubmed">16081920</ArticleId></ArticleIdList></Reference><Reference><Citation>Virol J. 2012 Sep 10;9:190</Citation><ArticleIdList><ArticleId IdType="pubmed">22962966</ArticleId></ArticleIdList></Reference><Reference><Citation>J Hum Genet. 2001;46(5):267-72</Citation><ArticleIdList><ArticleId IdType="pubmed">11355017</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Infect Dis. 2010 Sep;14(9):e775-80</Citation><ArticleIdList><ArticleId IdType="pubmed">20599410</ArticleId></ArticleIdList></Reference><Reference><Citation>Mediators Inflamm. 2013;2013:495848</Citation><ArticleIdList><ArticleId IdType="pubmed">23737648</ArticleId></ArticleIdList></Reference><Reference><Citation>J Interferon Cytokine Res. 2011 Feb;31(2):259-64</Citation><ArticleIdList><ArticleId IdType="pubmed">21087078</ArticleId></ArticleIdList></Reference><Reference><Citation>J Microbiol Immunol Infect. 2010 Aug;43(4):271-7</Citation><ArticleIdList><ArticleId IdType="pubmed">20688286</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>